Cargando…
Physiologic and molecular consequences of endothelial Bmpr2 mutation
BACKGROUND: Pulmonary arterial hypertension (PAH) is thought to be driven by dysfunction of pulmonary vascular microendothelial cells (PMVEC). Most hereditary PAH is associated with BMPR2 mutations. However, the physiologic and molecular consequences of expression of BMPR2 mutations in PMVEC are unk...
Autores principales: | Majka, Susan, Hagen, Moira, Blackwell, Thomas, Harral, Julie, Johnson, Jennifer A, Gendron, Robert, Paradis, Helene, Crona, Daniel, Loyd, James E, Nozik-Grayck, Eva, Stenmark, Kurt R, West, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141420/ https://www.ncbi.nlm.nih.gov/pubmed/21696628 http://dx.doi.org/10.1186/1465-9921-12-84 |
Ejemplares similares
-
Oxidative injury is a common consequence of BMPR2 mutations
por: Lane, Kirk L., et al.
Publicado: (2011) -
BMPR2 expression is suppressed by signaling through the estrogen receptor
por: Austin, Eric D, et al.
Publicado: (2012) -
Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene
por: Crona, Daniel, et al.
Publicado: (2009) -
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020) -
Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension
por: Johnson, Jennifer A, et al.
Publicado: (2009)